Adam Goldberger, Chief Financial Officer at QuantHealth
Dr. Adam Petrick, MD, Chief Medical Officer at QuantHealth
What You Should Know:
What You Should Know:
– QuantHealth, an AI-powered clinical trial design company that simulates clinical trials, announced…
Continue Reading
Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and…
Continue Reading
QuantHealth co-founders Arnon Horev and Orr (Ruti Benziman)
What You Should Know:
– In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic…
Continue Reading
What You Should Know:
– QuantHealth, an AI-powered clinical trial design startup, today announced a major product upgrade to its platform with the launch of Katina, a new tool that utilizes AI to simulate clinical…
Continue Reading
Pitango Venture Capital, one of the largest venture capital firms in Israel, announced on Wednesday the closing of a new $175 million healthcare fund.
The fund, named Pitango HealthTech II, is a sequel to Pitango’s…
QuantHealth, an AI-driven clinical trial design firm, has secured $15M in Series A funding led by Pitango HealthTech and Bertelsmann Investments. With a total raise of $20M, the Israeli company offers an AI-powered clinical…
Continue Reading
AI-enabled clinical trial design company QuantHealth announced it scored $15 million in a Series A funding round co-led by Pitango HealthTech and Bertelsmann Investments, bringing its total raise to $20 million. The company, which recently…
Continue Reading
QuantHealth co-founders Arnon Horev and Orr (Ruti Benziman)
What You Should Know:
– QuantHealth, an Israeli-based AI-powered clinical trial design startup raises $15M in a Series A funding round co-led by Bertelsmann Investments and Pitango HealthTech,…
Continue Reading
QuantHealth, an Israeli AI-enabled clinical trial-design startup, announced that David Dornstreich is joining the company as its general manager and chief commercial officer of U.S. operations, which marks its entry into the U.S. market. Dornstreich previously…
Continue Reading
